Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
4.080
+0.020 (0.49%)
Jul 3, 2026, 3:00 PM CST
SHA:600572 Market Cap
SHA:600572 has a market cap or net worth of 10.35 billion as of July 2, 2026. Its market cap has decreased by -8.96% in one year.
Market Cap
10.35B
Enterprise Value
9.75B
Revenue
6.69B
Ranking
n/a
PE Ratio
21.11
Stock Price
4.08
Market Cap Chart
Since April 12, 2004, SHA:600572's market cap has increased from 2.01B to 10.35B, an increase of 416.01%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 10.35B | -8.42% |
| Dec 31, 2025 | 11.30B | -3.24% |
| Dec 31, 2024 | 11.68B | -10.01% |
| Dec 29, 2023 | 12.98B | 6.77% |
| Dec 30, 2022 | 12.16B | -5.40% |
| Dec 31, 2021 | 12.85B | 6.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Garden Biopharmaceutical | 11.26B |
| Henan Lingrui Pharmaceutical | 11.25B |
| Zhejiang Medicine | 11.18B |
| Shanghai Shyndec Pharmaceutical | 11.04B |
| Guangdong Taienkang Pharmaceutical | 10.97B |
| Zhejiang Jingxin Pharmaceutical | 10.85B |
| Yantai Dongcheng Pharmaceutical Group | 10.54B |
| Frontier Biotechnologies | 9.96B |